Clinical Trial Update: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight [Phase 3]

View source ↗

Summary

Phase 3 trial investigating ixekizumab given with tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Psoriasis

Drugs mentioned

• Ixekizumab (ixekizumab)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Psoriasis, Obesity | Phase 3 | Status: COMPLETED